SPEVIGO
Live / Registered — Registered (as of 17 Oct 2023)
What this means for you
Registered since 17 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97278135
- Registration number
- 7197428
- Mark type
- Stylized text
- Filed
- 22 Feb 2022
- Published for opposition
- 27 Dec 2022
- Registered
- 17 Oct 2023
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, 55216 Ingelheim, DE
Prosecution history
- 17 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2023 — USE AMENDMENT FILED
- 02 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 21 Feb 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Dec 2022 — PUBLISHED FOR OPPOSITION
- 07 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Nov 2022 — ASSIGNED TO EXAMINER
- 28 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED